Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coursaget

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Seminars in Cancer Biology|March 14, 2000
Human papillomavirus vaccinesF Breitburd, P Coursaget
Nucleic Acids Research|April 4, 1998
In vitro gene transfer using human papillomavirus-like particlesA Touze, P Coursaget
Virologie (Montrouge, France)|November 4, 2021
[Human papillomavirus (HPV) vaccines]P Coursaget, A Touzé
Annales De Microbiologie|August 1, 1976
[The rate constant K37 in complement fixation tests: kinetic studies on the influenza virus-immune complex model (author's transl)]P Coursaget, P Maupas, R Vargues
Revue D'Histoire De La Pharmacie|October 20, 2001
[Philippe Maupas : hepatitis B vaccine discoverer]J P Chiron, P Coursaget, B Yvonnet
Journal of Immunological Methods|January 1, 1976
Automated complement fixation test for the detection of antibodies against the core of hepatitis B virus (HBc)P Coursaget, P Maupas, A Goudeau, et al.
The Journal of General Virology|March 22, 2000
DNA-containing and empty hepatitis B virus core particles bind similarly to envelope protein domainsC Hourioux, A Touzé, P Coursaget, et al.
Journal of Clinical Microbiology|January 16, 1999
Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassayA Touze, N Enogat, Y Buisson, et al.
Lancet (London, England)|July 14, 1979
Virus-like particles associated with non-A, non-B hepatitisP Coursaget, P Maupas, P Levin, et al.
Annales De Microbiologie|May 1, 1979
Comparison of sensitivity and specificity of counter electrophoresis, complement fixation and radioimmunoassay for detecting antibodies against hepatitis B core antigenP Coursaget, P Maupas, F Dubois, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Seminars in Cancer Biology|March 14, 2000
Human papillomavirus vaccinesF Breitburd, P Coursaget
Nucleic Acids Research|April 4, 1998
In vitro gene transfer using human papillomavirus-like particlesA Touze, P Coursaget
Virologie (Montrouge, France)|November 4, 2021
[Human papillomavirus (HPV) vaccines]P Coursaget, A Touzé
Annales De Microbiologie|August 1, 1976
[The rate constant K37 in complement fixation tests: kinetic studies on the influenza virus-immune complex model (author's transl)]P Coursaget, P Maupas, R Vargues
Revue D'Histoire De La Pharmacie|October 20, 2001
[Philippe Maupas : hepatitis B vaccine discoverer]J P Chiron, P Coursaget, B Yvonnet
Journal of Immunological Methods|January 1, 1976
Automated complement fixation test for the detection of antibodies against the core of hepatitis B virus (HBc)P Coursaget, P Maupas, A Goudeau, et al.
The Journal of General Virology|March 22, 2000
DNA-containing and empty hepatitis B virus core particles bind similarly to envelope protein domainsC Hourioux, A Touzé, P Coursaget, et al.
Journal of Clinical Microbiology|January 16, 1999
Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassayA Touze, N Enogat, Y Buisson, et al.
Lancet (London, England)|July 14, 1979
Virus-like particles associated with non-A, non-B hepatitisP Coursaget, P Maupas, P Levin, et al.
Annales De Microbiologie|May 1, 1979
Comparison of sensitivity and specificity of counter electrophoresis, complement fixation and radioimmunoassay for detecting antibodies against hepatitis B core antigenP Coursaget, P Maupas, F Dubois, et al.
Pageof 15